Dermata Therapeutics: Dermata to Present at the H.C. Wainwright BioConnect Conference

SAN DIEGO, CA / ACCESSWIRE / January 5, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic

Related Keywords

California ,United States ,San Diego ,Gerry Proehl ,Sean Proehl ,Hc Wainwright Bioconnect ,Wendell Wierenga ,Exchange Commission ,Dermata Therapeutics Inc ,Dermata Therapeutics ,Nasdaq ,Business Development ,Chief Executive Officer ,Bioconnect Virtual Conference ,Investor Relations ,Private Securities Litigation Reform Act ,Dermata ,Herapeutics ,Present ,Wainwright ,Bioconnect ,Conference ,